These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10090000)

  • 21. Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.
    Verbist L
    Antimicrob Agents Chemother; 1979 Aug; 16(2):115-9. PubMed ID: 485123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
    Rouhan D; Le Noc P; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B; Hall I; Curnow SR
    Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro activity of penicillin G plus sulbactam in comparison with other beta-lactamase inhibitor combinations and oxacillin against staphylococci.
    Jansen B; Perdreau-Remington F; Pulverer G
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):297-301. PubMed ID: 8837390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipseudomonal penicillins.
    Tan JS; File TM
    Med Clin North Am; 1995 Jul; 79(4):679-93. PubMed ID: 7791416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems].
    Schønning K; Tvede M
    Ugeskr Laeger; 2002 May; 164(20):2606-10. PubMed ID: 12043402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of beta-lactamase inhibitors.
    Rolinson GN
    Surg Gynecol Obstet; 1991; 172 Suppl():11-6. PubMed ID: 2024221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azlocillin: a new broad spectrum penicillin.
    Sanders CC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():21-31. PubMed ID: 6619029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of beta-lactam antibiotics in the treatment of septicaemia and endocarditis.
    Watanakunakorn C
    Scand J Infect Dis Suppl; 1984; 42():110-6. PubMed ID: 6442009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined action of beta-lactum antibiotics against gram-negative bacilli.
    Bobrowski MM; Gebicka K; Borowski J
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
    [No Abstract]   [Full Text] [Related]  

  • 37. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The penicillins.
    Wright AJ; Wilkowske CJ
    Mayo Clin Proc; 1983 Jan; 58(1):21-32. PubMed ID: 6218348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.
    Wise R; Gillett AP; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Apr; 13(4):559-65. PubMed ID: 96726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.